Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

G. Daniele, L. Arenare, G. Scambia, C. Pisano, R. Sorio, E. Breda, S. De Placido, A. Savarese, G. Ferrandina, F. Raspagliesi, P.B. Panici, A. Ferro, A. Rimanti, G. Cormio, D. Lorusso, S.C. Cecere, S. Scalone, V.A. Marsico, C. Cardalesi, F. CognettiV. Salutari, L. Attademo, L. Guizzaro, C. Schettino, M.C. Piccirillo, F. Perrone, C. Gallo, S. Pignata

Research output: Contribution to journalArticle

Cite this